Washington Trust Advisors’s Medline Inc MDLN Stock Holding History

Washington Trust Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.37M	Buy	+136,179	New	+$5.49M	0.4%	52

Other funds holding MDLN

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

BPCE

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

SAM

Sagewood Asset Management New York $442M AUM

PFM

Premier Fund Managers Guildford, United Kingdom $1.1B AUM 14.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Washington Trust Advisors's MDLN Position: Q2 2026 in Review

Washington Trust Advisors opened a new position in Medline Inc (MDLN) in Q2 2026: 136,179 shares worth $5.37M. The stake represents 0.4% of the portfolio and ranks #52 among its holdings.

98 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Washington Trust Advisors held 136,179 shares of Medline Inc worth $5.37M as of Q2 2026.
Medline Inc was a new Washington Trust Advisors position in Q2 2026.
Medline Inc made up 0.4% of Washington Trust Advisors's portfolio in Q2 2026, its #52 holding.
98 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.